President Trump's media company is looking for potential mergers and acquisitions as it aims to diversify beyond its current holdings.

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

Tencent Music plans a $2.4bn merger with Ximalaya, enhancing audio offerings and user retention. Read why we remain on the ...

Denver, Colorado--(Newsfile Corp. - April 25, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of ...

These growth stocks should also boast a good track record of increasing revenue and free cash flow, and enjoy a strong competitive position within their respective industries. Here are three growth ...

From improving fleet safety to optimizing insurance structure, here are smart, practical strategies to reduce exposure — and ...

CIO Robert Pick is both passionate and realistic about how artificial intelligence (AI) will impact the insurance industry.

Estonian-born Airi Hammalov LLM ’01 visited New York for the very first time. It was love at first sight. Three years later, when she earned a Fulbright scholarship to study law, she saw her best ...

“There is an obvious conflict of interest,” Matt Levine, a former mergers and acquisitions lawyer who is a columnist for Bloomberg News, wrote Monday. “If you are, say, an xAI shareholder ...

The combined company has been renamed Liminatus Pharma, Inc., and its common stock and warrants are expected to commence trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the new ticker symbols ...